Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study

OBJECTIVES: Patients with stage 3 medication-related osteonecrosis of the jaw (MRONJ) suffer from severe complications. Chemotherapeutic agents and targeted drugs are considered to be associated with the development of MRONJ. However, little is known regarding the association of those agents with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yuqiong, Yu, Yejia, Shi, Yueqi, Li, Mengyu, Yang, Chi, Wang, Shaoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584964/
https://www.ncbi.nlm.nih.gov/pubmed/33123580
http://dx.doi.org/10.1155/2020/5847429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584964/
https://www.ncbi.nlm.nih.gov/pubmed/33123580
http://dx.doi.org/10.1155/2020/5847429

Ejemplares similares